Monthly Newsletter from the Arizona Asthma Coalition |
|
|
14th Annual Virtual Clinical Asthma & Allergy Conference
Thank you to all who joined us virtually on September 12th for live presentations! Recorded sessions are available on-demand through October 31, 2020. Sign up to access the sessions on demand now
|
|
|
COVID-19 & Asthma Town Hall October 14, 2020 | 12 p.m.
The American Lung Association in Arizona and the American Lung Association in New Mexico invite you to participate in a FREE virtual town hall to discuss the ongoing impacts of COVID-19. Asthma, one of the leading chronic lung diseases, affects nearly 25 million Americans and puts them at higher risk for developing severe symptoms from COVID-19. This webinar will review the health implications COVID-19 has on both children and adults living with Asthma.Sign up here
|
|
|
|
|
Working to End the Sale of Flavored Tobacco Products
Arizona Asthma Coalition is proud to support Flavors Hook Kids Phoenix to help take down flavored tobacco for good and protect Phoenix youth and communities of color.
Join the campaign here |
|
|
COVID-19–related Genes in Sputum Cells in Asthma
American Journal of Respiratory and Critical Care MedicineCoronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ACE2 (angiotensin-converting enzyme 2), and TMPRSS2 (transmembrane protease serine 2) mediate viral infection of host cells. We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity.
Read more |
|
|
COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids? American Journal of Respiratory and Critical Care Medicine
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a real pandemic. After a median incubation period of 5 days, the disease occurs in different stages, inducing upper and lower airway responses in mild disease (80–90% of patients) and progressing to bilateral pneumonia in severe disease (10–20%) (1–3). A subgroup of patients with severe COVID-19 develops acute respiratory distress syndrome, requiring mechanical ventilation on intensive care. COVID-19 patients with preexisting comorbid conditions such as chronic respiratory diseases have worse disease outcomes, including a higher incidence of the need for hospitalization, ICU admission, and mortality (3, 4). However, it remains to be further investigated how preexisting chronic inflammatory airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and their treatment might modify the risk for SARSCoV-2 infection and development of COVID-19.
Read more |
|
|
Follow Our New Facebook Page Arizona Asthma Coalition is now on Facebook! Head over to Facebook and like AAC to keep up to date on asthma, allergy and organizational updates in between our monthly newsletters. Follow us here |
|
|
Join the Arizona Asthma Coalition As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues. Become a member of the Arizona Asthma Coalition or renew your membership and help us continue this important work. Join or renew here |
|
|
Support AAC While You Shop! AmazonSmile is a website operated by Amazon with the same products, prices, and shopping features as Amazon.com. The difference is that when you shop on AmazonSmile, the AmazonSmile Foundation will donate 0.5% of the purchase price of eligible products to the charitable organization of your choice. Designate Arizona Asthma Coalition as your charity of choice and you can support our efforts to address the growing and serious problems related to asthma in Arizona. Click here & select Arizona Asthma Coalition |
|
|
|
|
|
